Live Attenuated Vaccines Market - Global Industry Analysis, Market Size, Opportunities and Forecast 2021 - 2030

Live-attenuated vaccines are very effective vaccines used in the prevention of a variety of diseases including influenza, chickenpox, measles, polio and TB. Live-attenuated vaccines can be produced by reverse genetics including RNAi.

  • Last Updated: 02 Jun 2021
  • Report Code: ARC2653
  • Category: Healthcare and Pharmaceuticals

Looking for discounts, bulk pricing, or custom solutions? Contact us today at [email protected]

Frequently Asked Questions

Rise in cases of infectious diseases across the globe and ongoing clinical trials by major pharmaceutical players are major factors expected to drive the growth of global live attenuated vaccines market.

In product type the viral segment is growing at faster pace.

In the global market the Asia Pacific region is expected to grow faster.

Some of the players considered in the report scope are Sanofi, Emergent BioSolutions Inc, GlaxoSmithKline plc, Daiichi Sankyo Company, Limited, and AstraZeneca.

The North America is expected to account for major revenue share in the global market.

In end use the hospital segment is growing at faster pace.

Factors such as high cost associated to R&D activities and stringent government regulations related to product approval are expected to hamper the growth of global live attenuated vaccines market.

Frequently Asked Questions

Rise in cases of infectious diseases across the globe and ongoing clinical trials by major pharmaceutical players are major factors expected to drive the growth of global live attenuated vaccines market.

In product type the viral segment is growing at faster pace.

In the global market the Asia Pacific region is expected to grow faster.

Some of the players considered in the report scope are Sanofi, Emergent BioSolutions Inc, GlaxoSmithKline plc, Daiichi Sankyo Company, Limited, and AstraZeneca.

The North America is expected to account for major revenue share in the global market.

In end use the hospital segment is growing at faster pace.

Factors such as high cost associated to R&D activities and stringent government regulations related to product approval are expected to hamper the growth of global live attenuated vaccines market.
Select Licence Type
Single User
$4500
Multi User
$7000
MOST POPULAR
Excel Datapack
$2000
Request Sample Request Customization

Your decisions deserve reliable insights — contact our team today.

Contact Us